Furthermore, we show that the inhibition of menin reduces total cellular cholesterol in these same models and that menin inhibitors and LXR activators have a similar ability to suppress CRC cell growth when combined with either small molecule EGFR inhibitors or cholesterol-depleted conditions. This evidence concerns the gene EGFR and colorectal carcinoma.